You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies

Article metrics

Article menu
XML
Basic tumor immunology
Original research
Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies

 

Online download statistics by month:

Online download statistics by month: November 2020 to January 2026

AbstractFullPdf
Nov 2020234234140
Dec 202015215289
Jan 20219999108
Feb 2021585828
Mar 2021747443
Apr 2021646432
May 2021464624
Jun 2021363620
Jul 2021393927
Aug 2021515131
Sep 2021484825
Oct 202195195153
Nov 2021585854
Dec 2021464632
Jan 2022576833
Feb 2022354124
Mar 2022555922
Apr 2022495223
May 2022595930
Jun 2022495123
Jul 2022525327
Aug 2022606020
Sep 2022595962
Oct 2022566831
Nov 2022343425
Dec 2022343414
Jan 2023838328
Feb 2023858632
Mar 2023616345
Apr 2023303019
May 2023595920
Jun 2023535424
Jul 2023383825
Aug 2023686822
Sep 202310810814
Oct 202322422414
Nov 202349149222
Dec 2023414219
Jan 2024282919
Feb 202426269
Mar 2024565732
Apr 2024474716
May 2024333814
Jun 2024404122
Jul 2024474933
Aug 20245151115
Sep 2024252611
Oct 2024505020
Nov 2024465021
Dec 2024434416
Jan 2025555520
Feb 2025343426
Mar 2025555544
Apr 2025585816
May 2025343517
Jun 2025232315
Jul 2025110
Sep 2025110
Jan 2026110
Total465047121790